Main Menu
Search
Close this search box.
Donate
Sign Up

Developing Nanoneedle Technology

TECHNOLOGY VALUE

The technology will be optimized for easy clinical adoption and scaled up so that numerous FDA-approved drugs can be simultaneously screened as potential treatments.

LEAD INVESTIGATORS
  • Rahim Esfandyarpour, PhD
  • Ronald W. Davis, PhD
  • Rahim Esfandyarpour, PhD
  • Ronald W. Davis, PhD
UPDATES AND POTENTIAL
Coming soon...

Coming soon…

TECHNOLOGY DESCRIPTION

Man holding a diagnostic chip in his handThe nanoneedle biosensor is a cost-effective, versatile, ultrasensitive and high-throughput nanoelectronics device. This device measures the electrical impedance of cells from a single drop of blood.

TECHNOLOGY DEVELOPMENT

This test is able to distinguish ME/CFS patients from healthy controls.

An analysis of over 40 ME/CFS patients and controls has established that cells from the blood of ME/CFS patients exhibit a characteristic impedance pattern when subjected to salt stress that is significantly different than the controls.

Future tests of this device will be made to:

  • Determine if differences are observed between ME/CFS patients and other related diseases.
  • Whether impedance signals are indicative of illness severity by testing a series of patients at altered severity.
  • To test candidate drugs to see if the salt stress impedance signal can be returned to healthy control levels, revealing the potential of the nanosensor array platform for use in drug screening.

Other links you might be interested in:

The Ronald G. Tompkins ME/CFS Collaboration at the Harvard Affiliated Hospitals
University of Montreal Collaborative Research Center
Facebook Twitter Youtube Instagram Linkedin

OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.

Open Medicine Foundation®
29302 Laro Drive,  Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo

Contact Us

PRIVACY  |  COOKIE   |   CONSENT   |  MEDICAL & OTHER DISCLAIMERS

Copyright © 2024 Open Medicine Foundation. All Rights Reserved.

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 
 
Donate